MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$2,516,000
EPS
-$0.07
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-04-30
2026-01-31
2025-10-31
2025-07-31
Revenue
-
-
-
0
Research and development expenses (including non-cash stock-based compensation expenses of 286, 417, 624 and 814, respectively)
1,258,000
1,102,000
1,505,500*
1,055,000
General and administrative expenses (including non-cash stock-based compensation expenses of 379, 571, 837 and 1,229, respectively)
1,389,000
1,614,000
2,037,000*
1,381,000
Total operating expenses
2,647,000
2,716,000
3,542,500
2,436,000
Loss from operations
-2,647,000
-2,716,000
-3,542,500*
-2,436,000
Interest income
111,000
131,000
154,000*
156,000
Net loss
-2,536,000
-2,585,000
-3,388,500*
-2,280,000
Less net loss attributable to noncontrolling interest
-20,000
-20,000
-33,500*
-22,000
Net loss attributable to common shareholders
-2,516,000
-2,565,000
-3,355,000
-2,258,000
Basic EPS
-0.07
-0.08
0.052
-0.07
Diluted EPS
-0.07
-0.08
0.052
-0.07
Basic Average Shares
33,593,000
33,240,000
-64,580,638
32,476,000
Diluted Average Shares
33,593,000
33,240,000
-64,580,638
32,476,000
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to common...
-$2,516,000
(9.82%↑ Y/Y)
Less net loss
attributable to...
-$20,000
(13.04%↑ Y/Y)
Net loss
-$2,536,000
(9.85%↑ Y/Y)
Interest income
$111,000
(-41.58%↓ Y/Y)
Loss from operations
-$2,647,000
(11.85%↑ Y/Y)
Total operating
expenses
$2,647,000
(-11.85%↓ Y/Y)
General and
administrative expenses...
$1,389,000
(-17.37%↓ Y/Y)
Research and development
expenses (including...
$1,258,000
(-4.84%↓ Y/Y)
Buy us a coffee
Anixa Biosciences Inc (ANIX)
Anixa Biosciences Inc (ANIX)